Arnaud L - Search Results

1

Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years.

Piras F, Arnaud L, Henninger E, Keiser M, Seitzinger A, Jack D, Le Masne Q. Piras F, et al. Among authors: arnaud l. Expert Opin Drug Deliv. 2023 Jun;20(6):863-870. doi: 10.1080/17425247.2023.2221432. Epub 2023 Jun 7. Expert Opin Drug Deliv. 2023. PMID: 37273189

2

Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.

Spataru A, van Dommelen P, Arnaud L, Le Masne Q, Quarteroni S, Koledova E. Spataru A, et al. Among authors: arnaud l. BMC Med Inform Decis Mak. 2022 Jul 6;22(1):179. doi: 10.1186/s12911-022-01918-2. BMC Med Inform Decis Mak. 2022. PMID: 35794586 Free PMC article.

3

High Engagement of Patients Monitored by a Digital Health Ecosystem Indicates Significant Improvements of Key r-hGH Treatment Metrics.

Spataru A, Quarteroni S, Arnaud L, van Dommelen P, Koledova E, Le Masne Q. Spataru A, et al. Among authors: arnaud l. Stud Health Technol Inform. 2021 May 27;281:829-833. doi: 10.3233/SHTI210295. Stud Health Technol Inform. 2021. PMID: 34042790

4

Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis.

Tornincasa V, Dixon D, Le Masne Q, Martin B, Arnaud L, van Dommelen P, Koledova E. Tornincasa V, et al. Among authors: arnaud l. Front Endocrinol (Lausanne). 2022 Jun 30;13:882192. doi: 10.3389/fendo.2022.882192. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846336 Free PMC article.

5

Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.

Assefi A, van Dommelen P, Arnaud L, Otero C, Fernandez-Luque L, Koledova E, Calliari LE. Assefi A, et al. Among authors: arnaud l. JMIR Mhealth Uhealth. 2022 Jan 20;10(1):e32626. doi: 10.2196/32626. JMIR Mhealth Uhealth. 2022. PMID: 35049518 Free PMC article.

6

Curve matching to predict growth in patients receiving growth hormone therapy: An interpretable & explainable method.

van Dommelen P, Arnaud L, Koledova E. van Dommelen P, et al. Among authors: arnaud l. Front Endocrinol (Lausanne). 2022 Oct 5;13:999077. doi: 10.3389/fendo.2022.999077. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36277722 Free PMC article.

7

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.

Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H, McAvoy C, Lacombe V, Ardois S, Campochiaro C, Maria A, Coustal C, Comont T, Lazaro E, Lifermann F, Le Guenno G, Lobbes H, Grobost V, Outh R, Campagne J, Dor-Etienne A, Garnier A, Jamilloux Y, Dossier A, Samson M, Audia S, Nicolas B, Mathian A, de Maleprade B, De Sainte-Marie B, Faucher B, Bouaziz JD, Broner J, Dumain C, Antoine C, Carpentier B, Castel B, Lartigau-Roussin C, Crickx E, Volle G, Fayard D, Decker P, Moulinet T, Dumont A, Nguyen A, Aouba A, Martellosio JP, Levavasseur M, Puigrenier S, Antoine P, Giraud JT, Hermine O, Lacout C, Martis N, Karam JD, Chasset F, Arnaud L, Marianetti P, Deligny C, Chazal T, Woaye-Hune P, Roux-Sauvat M, Meyer A, Sujobert P, Hirsch P, Abisror N, Fenaux P, Kosmider O, Jachiet V, Fain O, Terrier B, Mekinian A, Georgin-Lavialle S; FRENVEX. Hadjadj J, et al. Among authors: arnaud l. Ann Rheum Dis. 2024 May 22:ard-2024-225640. doi: 10.1136/ard-2024-225640. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38777378

8

Long-read sequencing unravels the complexity of structural variants in PRKN in two individuals with early-onset Parkinson's disease.

Cogan G, Daida K, Billingsley KJ, Tesson C, Forlani S, Jornea L, Arnaud L, Tissier L, LeGuern E, Singleton AB, Ferrien M, Gervais Bernard H, Lesage S, Blauwendraat C, Brice A. Cogan G, et al. Among authors: arnaud l. medRxiv [Preprint]. 2024 May 3:2024.05.02.24306523. doi: 10.1101/2024.05.02.24306523. medRxiv. 2024. PMID: 38746197 Free PMC article. Preprint.

9

Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes.

Smati S, Sotin T, Deniel P, Ducheix S, Joubert M, Arnaud L, Hadjadj S, Cariou B, Le May C, Prieur X. Smati S, et al. Among authors: arnaud l. Diabetes Obes Metab. 2024 May 3. doi: 10.1111/dom.15634. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38699785 No abstract available.

10

Relapsing polychondritis: clinical updates and new differential diagnoses.

Mertz P, Costedoat-Chalumeau N, Ferrada MA, Moulis G, Mekinian A, Grayson PC, Arnaud L. Mertz P, et al. Among authors: arnaud l. Nat Rev Rheumatol. 2024 Jun;20(6):347-360. doi: 10.1038/s41584-024-01113-9. Epub 2024 May 2. Nat Rev Rheumatol. 2024. PMID: 38698240 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page